Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
Status:
Terminated
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
THE STUDY HAS BEEN DESIGNED TO COMPARE THE EFFICACY OF TWO DOSES (25 MG AND 100 MG) OF
RIFAXIMIN VAGINAL TABLETS VERSUS PLACEBO IN SUBJECTS WITH BACTERIAL VAGINOSIS